MACKAY SHIELDS LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 37 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MACKAY SHIELDS LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$252,518
+12.2%
135,0000.0%0.01%0.0%
Q3 2022$225,000
+32.4%
135,000
-0.7%
0.01%
+50.0%
Q2 2022$170,000
-4.0%
136,000
+0.7%
0.00%
+100.0%
Q1 2022$177,000
-10.6%
135,0000.0%0.00%0.0%
Q4 2021$198,000
-1.0%
135,0000.0%0.00%0.0%
Q3 2021$200,000
+12.4%
135,0000.0%0.00%0.0%
Q2 2021$178,000
+0.6%
135,0000.0%0.00%
+100.0%
Q1 2021$177,000
-46.5%
135,0000.0%0.00%
-50.0%
Q4 2020$331,000
+18.2%
135,0000.0%0.00%0.0%
Q3 2020$280,000
-9.7%
135,0000.0%0.00%0.0%
Q2 2020$310,000
+51.2%
135,0000.0%0.00%0.0%
Q1 2020$205,000
-22.1%
135,0000.0%0.00%0.0%
Q4 2019$263,000
-73.7%
135,000
-82.1%
0.00%
-66.7%
Q3 2019$999,000
-93.3%
755,000
-88.7%
0.01%
-94.1%
Q2 2019$14,937,000
+33.2%
6,703,000
+8.2%
0.10%
+25.9%
Q1 2019$11,213,0006,193,0000.08%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 53,865,000$101,127,2803.93%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 88,657,000$165,397,6133.42%
Boussard & Gavaudan Investment Management LLP 11,898$21,871,5382.42%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,394,000$71,834,2261.71%
WOLVERINE ASSET MANAGEMENT LLC 79,876,000$149,367,3841.55%
CSS LLC/IL 4,747,000$8,868,6060.50%
Opti Capital Management, LP 3,000,000$5,611,9380.48%
Verition Fund Management LLC 16,459,000$30,786,5600.48%
Aequim Alternative Investments LP 5,000,000$9,352,5000.25%
MIZUHO SECURITIES USA LLC 1,097,000$2,047,6160.19%
View complete list of SAREPTA THERAPEUTICS INC shareholders